SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 11th, 2021 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 11th, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of February 9, 2021, between Outlook Therapeutics, Inc., a Delaware corporation (the “Company”), and GMS Ventures and Investments (including its successors and assigns, “Purchaser”).